Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

16/05/2017 CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials 14/05/2017 SPIRIT 2013 Statement: Defining standard protocol items for clinical trials 23/10/2016 Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement 20/08/2013 Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration 14/08/2013 Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials 14/08/2013 Electrodermal activity at acupoints: literature review and recommendations for reporting clinical trials 13/08/2013 ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis 12/08/2013 American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation 08/08/2013 Guidelines for the reporting of renal artery revascularization in clinical trials 07/08/2013 Reporting standards for carotid artery angioplasty and stent placement

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More